AMPK activation through phosphorylation inhibits de novo FA biosynthesis through phosphorylation and repression of the lipogenic transcription factor, SREBP1, which regulates the expression of FASN [11], androgen receptor expression and PCa progression [26, 27]. The gene discussed is AR; the disease is posterior cortical atrophy.